TITLE 21
READY-TO-GO CMC SERIES
GENERIC DRUG DEVELOPMENT CMC KNOW-HOW LIST

Contents of a Ready-To-Go Dossier

RTG	DRUG PRODUCT	FORM	Strength	USD	Sterling
99	Silver Sulphadiazine	Cream	1%	A	A
100	Tamoxifen EU Aqueous Coated	Tablets	10 / 20 mg	B	B
101	Tamoxifen EU Aqueous Coated	Tamoxifen EU	30 / 40mg	C	C
102	Tamoxifen US Aqueous Coated	Tablets	10/20/40mg	B	B
103	Tamoxifen US Non Coated	Tablets	10/20/40mg	B	B
104	Terbutaline Sulfate	Syrup	0.3 mg/mL	B	B
105	Terazosin US/EU	Tablets	1mg / 2mg	B	B
106	Terfenazine US/EU	Tablets	60 mg	B	B
107	Tetrahydrozoline HCl USP	Eye Drops	2,5mg/5mL	B	B
108	Ticlopidine US/EU	Tablets	250 mg	B	B
109	Timolol maleate Drops USP	Eye Drops	0.25 / 0.5%	C	C
110	Tolmetin Sod. US/EU	Capsules	400 mg	B	B
111	Tolmetin Sod. US/EU	Tablets	600 mg	B	B
112	Trazodone US/EU	Tablets	50/100 mg	C	C
113	Trazodone US/EU	Tablets	150 mg	C	C
114	Tretinoin	Cream USP	0.025% 0.05%	C	C
115	Sulfamethoxazole Trimethoprim	Tablets USP	80/400mg	B	B
116	Sulfamethoxazole Trimethoprim DS	Tablets USP	160/800mg	C	C
117	Sulfamethoxazole Trimethoprim	Suspension	80/400mg	B	B
118	Sodium Valproate	Tablets	40/80/120mg	B	B
119	Verapamil Hydrochloride	Tablets	40/80/120mg	C	C
[List 1] [List 2] [List 3][List 4][List 5]

NOTE: EULA and IAGIM Rules / Regulations apply to Ready-To-Go CMC Series

DOWNLOAD The Ready-To-Go List - (PDF Format)

IAGIM's Ready-To-Go CMC Drug Development Know-How Series may be downloaded as a current reference source.